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Abstract Acid-base conditions modify artery tone and tissue perfusion but the involved
vascular-sensing mechanisms and disease consequences remain unclear. We experimentally
investigated transgenic mice and performed genetic studies in a UK-based human cohort. We show
that endothelial cells express the putative HCO3
–-sensor receptor-type tyrosine-protein
phosphatase RPTPg, which enhances endothelial intracellular Ca2+-responses in resistance arteries
and facilitates endothelium-dependent vasorelaxation only when CO2/HCO3
– is present. Consistent
with waning RPTPg-dependent vasorelaxation at low [HCO3
–], RPTPg limits increases in cerebral
perfusion during neuronal activity and augments decreases in cerebral perfusion during
hyperventilation. RPTPg does not influence resting blood pressure but amplifies hyperventilation-
induced blood pressure elevations. Loss-of-function variants in PTPRG, encoding RPTPg, are
associated with increased risk of cerebral infarction, heart attack, and reduced cardiac ejection
fraction. We conclude that PTPRG is an ischemia susceptibility locus; and RPTPg-dependent sensing
of HCO3
– adjusts endothelium-mediated vasorelaxation, microvascular perfusion, and blood
pressure during acid-base disturbances and altered tissue metabolism.
Introduction
Inadequate tissue perfusion relative to metabolic demand is a fundamental pathophysiological cause
of acute (e.g. myocardial infarction and stroke) and chronic (e.g. heart failure and neurodegenerative
disorders) cardiovascular disease. Newer treatment options improve the prognosis for some of these
debilitating conditions but we need alternative therapeutic strategies in order to minimize ischemia-
related morbidity and mortality.
Sensing of the chemical environment in the wall of arteries coordinates local blood flow to meet
the oxidative metabolic demand and counteract ischemia. Despite their obvious clinical importance,
the cellular and molecular mechanisms responsible for sensing metabolic disturbances and respond-
ing to inadequate perfusion are not well understood (Boedtkjer, 2018). Local acidification is an
important signal of insufficient nutrient delivery and waste product elimination. Although functional
effects of H+ in the vascular wall have long been appreciated (Boedtkjer, 2018; Gaskell, 1880;
Boedtkjer et al., 2016a; Boedtkjer and Aalkjaer, 2012; Boedtkjer and Aalkjaer, 2013a;
Boedtkjer and Aalkjaer, 2013b), the consequences of associated changes in CO2/HCO3
– buffer
composition have received far less attention. CO2 and HCO3
– constitute an important buffer pair that
minimizes acute changes in pH (Roos and Boron, 1981), improves spatial H+ mobility
(Spitzer et al., 2002; Boedtkjer et al., 2016b), and provides substrate for acid-base transporters in
cell membranes (Aalkjaer and Hughes, 1991; Boedtkjer et al., 2006). Evidence supports that cells
also possess sensors that respond to changes in [HCO3
–] in the intracellular and extracellular space
(Zhou et al., 2016; Boedtkjer et al., 2016c; Chen et al., 2000). Interventions—such as NaHCO3
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supplementation—that modify systemic acid-base status are available (Voss et al., 2020) but
expected to carry considerable adverse effects and be too general for cardiovascular therapy. The
identification of HCO3




–-sensors) opens largely unexplored avenues for pharmacological treat-
ment. Because the vasculature of vital organs—particularly the brain and heart—responds to meta-
bolic deregulation and is sensitive to acid-base disturbances, it is likely that therapy targeting HCO3
–-
related proteins will be able to modify myocardial and cerebral perfusion preferentially in areas of
unmet metabolic demand.
Through mechanisms that require the transmembrane Receptor Protein Tyrosine Phosphatase
(RPTP)g , isolated decreases in extracellular [HCO3
–] enhance HCO3
– reabsorption in the renal proximal
tubule (Zhou et al., 2016) and contractions of basilar arteries (Boedtkjer et al., 2016c) when pCO2
and pH are kept constant using out-of-equilibrium technology (Zhao et al., 1995). The extracellular
domain of RPTPg resembles the active site of the carbonic anhydrases (Barnea et al., 1993) and
therefore likely binds HCO3
–. However, the carbonic anhydrase-like domain of RPTPg lacks the histi-




þ (Zhou et al., 2016). Instead, HCO3
– may induce a dimerization-depen-
dent auto-inhibitory response in RPTPg and thereby regulate signaling via the intracellular tyrosine
phosphatase domains (Barr et al., 2009). Apart from these structural observations, we do not cur-
rently understand the cellular and molecular mechanisms for impact of HCO3
– and RPTPg on resis-
tance artery function, blood pressure, and control of tissue perfusion. Although CO2 has no direct
net effect on cerebrovascular tone (Boedtkjer et al., 2016c), respiratory changes leading to hyper-
or hypocapnia will lead to secondary rises or falls in [HCO3
–] and pH that in turn influence artery con-
tractions and tissue perfusion.
In the present study, we demonstrate—based on experimental investigations in transgenic
mice—that RPTPg (a) facilitates endothelium-dependent relaxation of resistance arteries through
mechanisms regulated by extracellular HCO3
– and (b) adjusts microvascular perfusion and blood pres-
sure during increased tissue metabolism and acid-base disturbances. Through translational genetic
studies in the UK Biobank cohort (Bycroft et al., 2018), we further substantiate the importance of
eLife digest Restricted blood flow in the heart or brain can deprive these vital organs of
oxygen, thereby causing a heart attack or stroke. However, the body has compensatory mechanisms
to mitigate damage: if the blood flow is reduced in one blood vessel, acidic waste accumulates
locally. This causes nearby blood vessels to widen and increase the oxygen supply. Although
scientists first observed this process 140 years ago, they have not yet devised a way to use it for
treatment of heart attack or stroke.
Now, Hansen et al. discovered that a protein called RPTPg, which is found on the lining of blood
vessels, could be a good target for drugs intended to reduce the consequences of heart attacks and
strokes. The protein RPTPg has a similar structure to other proteins that bind bicarbonate, an
important ion that buffers acids in the body. RPTPg can also trigger signals to nearby cells, which
suggests that the protein can monitor bicarbonate levels in the blood and tissue and alert blood
vessels of the need to widen.
Hansen et al. found that the blood vessels of mice that lacked RPTPg were unable to widen when
needed. Moreover, mice without RPTPg experienced abnormal changes in blood pressure and
blood flow to the brain when oxygen consumption was elevated or pH was disrupted. Hansen et al.
further analyzed genetic and health data from nearly 50,000 individuals in the UK Biobank. These
analyses revealed that people with genetic changes that render RPTPg ineffective are at higher risk
of having a heart attack or stroke. People with these genetic variants also have reduced heart
pumping ability.
The experiments suggest that a lack of functional RPTPg affects an individual’s ability to adjust
local blood flow in response to acid-base disturbances and oxygen deficits, increasing the risk of a
heart attack or stroke. This information may help scientists develop new ways to prevent or treat
heart attacks and strokes, or to treat other conditions like cancer, where pH is disturbed.
Hansen et al. eLife 2020;9:e57553. DOI: https://doi.org/10.7554/eLife.57553 2 of 26
Research article Genetics and Genomics Medicine
the identified mechanisms for human cardiovascular health as we demonstrate that predicted loss-
of-function variants in PTPRG, encoding RPTPg, are associated with human ischemic vascular disease
in the heart and brain.
Results
Ptprg is widely expressed in the vascular endothelium
We first evaluated promoter activity for Ptprg by b-galactosidase staining of mice with a promoter-
less LacZ insert under transcriptional control of the Ptprg promoter. We found signs of prominent
Ptprg transcriptional activity in the endothelium of mouse basilar, middle cerebral, and coronary
arteries (Figure 1A). We also saw signs of Ptprg transcriptional activity in pulmonary and skeletal
muscle arteries, whereas transcription of Ptprg appeared lower in the aorta and mesenteric arteries
(Figure 1A).
Since promoter activity is no direct measure of expression—and cytosolic dilution of the chromo-
genic reaction product lowers the sensitivity of the b-galactosidase reporter assay—we followed up
with quantitative RT-PCR analyses that confirmed substantial steady-state levels of Ptprg mRNA in
basilar, middle cerebral, coronary, and pulmonary arteries and identified clearly detectable levels in
the aorta, mesenteric, and skeletal muscle arteries (Figure 1B).
We next explored the endothelial expression pattern of Ptprg based on single-cell transcriptomic
data from healthy mice (Kalucka et al., 2020). These data verify Ptprg expression in the vascular
endothelium of the brain, heart, lung, skeletal muscle, and small intestine (Figure 1C,D). The data
further show that the endothelial Ptprg expression extends from the arterial vasculature, across
capillaries, and into the veins (Figure 1D,E).
Taken together, we identify widespread endothelial Ptprg expression with prominent levels in the
cerebral and coronary vasculature where metabolites, including acid-base equivalents, strongly influ-
ence arterial tone (Gaskell, 1880; Boedtkjer et al., 2016c; Wahl et al., 1970).
RPTPg enhances endothelium-dependent vasorelaxation
Isolated small arteries pre-contracted with the thromboxane A2 analog U46619 relaxed concentra-
tion-dependently in response to the classical endothelium-dependent agonist acetylcholine (Fig-
ure 2). In order to evaluate a distinct additional endothelial signaling pathway (D’Andrea et al.,
1998) capable of inducing potent endothelium-dependent vasorelaxation of cerebral and mesen-
teric small arteries (Boedtkjer et al., 2013a; McNeish et al., 2005; Bucci et al., 2005), we also
tested the effect of the proteinase-activated receptor (PAR)2 agonist SLIGRL-amide (Figure 3).
Under physiological conditions with CO2/HCO3
– present in the buffer solutions, acetylcholine- and
SLIGRL-amide-induced vasorelaxation of basilar (Figures 2A–C and 3A–C), mesenteric (Figures 2I
and 3I), and coronary (Figures 2M and 3L) arteries from RPTPg knockout (KO) mice was reduced
compared to arteries from wild type (WT) mice. We observed this difference between arteries from
RPTPg KO and WT mice whether experiments in presence of CO2/HCO3
– were conducted with
(Figures 2B and 3B) or without (Figures 2C and 3C) the non-physiological buffer HEPES. Addition
of an artificial buffer is necessary for pH control in absence of CO2/HCO3
–; and we included HEPES
also in the CO2/HCO3
–-containing solutions in order to separate the vascular effects of CO2/HCO3
–
omission from potential effects of adding HEPES (Altura et al., 1980). Acetylcholine-induced vasore-
laxation of basilar arteries from RPTPg KO mice was suppressed in presence of CO2/HCO3
– mostly
because of attenuated NO-dependent (i.e. N-nitro-L-arginine methyl ester (L-NAME)-sensitive) sig-
naling (Figure 2D–G). In contrast, the diminished vasorelaxation of basilar arteries in response to
SLIGRL-amide (Figure 3D–F) and of mesenteric and coronary arteries in response to acetylcholine
(Figure 2J–L and Figure 2N–P) and SLIGRL-amide (Figure 3J,K,M,N) was mostly explained by
smaller endothelium-dependent hyperpolarization (EDH)-type responses that were L-NAME-insensi-
tive but inhibited by apamin and TRAM-34. Consistent with these findings, L-NAME-insensitive
smooth muscle hyperpolarization was significantly attenuated in basilar arteries from RPTPg KO mice
when elicited by SLIGRL-amide (Figure 3G,H) but not when elicited by acetylcholine (Figure 2H).
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Figure 1. Profiles of Ptprg transcriptional activity and mRNA levels demonstrate widespread expression across arterial, capillary, and venous endothelial
cells and in diverse vascular beds including cerebral and coronary arteries. (A) Histochemical staining for b-galactosidase activity reports the Ptprg
transcriptional activity in PtprgLacZ/LacZ mice. The scale bars indicate 5 and 50 mm for the histological and whole-mount images, respectively, and all
images within each category are displayed at the same magnification except for the image of the aorta where the scale bar corresponds to 150 mm.
Figure 1 continued on next page
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The vasorelaxant influence of RPTPg depends on CO2/HCO3
–
In order to evaluate whether RPTPg-dependent signaling is influenced by HCO3
– in the vascular wall,
we next repeated studies of endothelium-dependent vasorelaxation using nominally CO2/HCO3
–-
free, HEPES-buffered solutions (Figure 4). Under these conditions, we saw no RPTPg-dependent dif-
ferences in overall vasorelaxant function of basilar or mesenteric arteries in response to acetylcholine
(Figure 4A,B,G) or SLIGRL-amide (Figure 4K,L,P). The relative contribution of NO-dependent sig-
naling and EDH-type responses to vasorelaxation was also not significantly affected by RPTPg KO in
basilar (Figure 4C–F) or mesenteric (Figure 4H–J) arteries in response to acetylcholine. Whereas the
dependency on NO-signaling vs EDH-type vasorelaxation in response to SLIGRL-amide was likewise
not affected in mesenteric arteries (Figure 4Q,R), we saw indications of an apparent relative increase
in NO-mediated vasorelaxation when basilar arteries from RPTPg KO mice were stimulated with
SLIGRL-amide in absence of CO2/HCO3
– (Figure 4M–O). This unexpected change in the relative
importance of the underlying vasorelaxant mechanisms in basilar arteries could be a compensation
secondary to the predominant inhibition of NO-dependent vasorelaxation in these arteries in pres-
ence of CO2/HCO3
– (Figure 2F) and hence presumably in vivo.
NO-synthase expression and responses to NO donors are largely
independent of RPTPg
We next explored the mechanism whereby RPTPg influences resistance artery function (Figure 5).
We first evaluated whether the difference in vasorelaxation between arteries from RPTPg KO and
WT mice depends on a change in expression of the endothelial NO-synthase (eNOS). Based on
immunoblotting of basilar (Figure 5A) and mesenteric (Figure 5D) arteries, we found equal eNOS
expression between arteries from RPTPg KO and WT mice.
We also evaluated whether the smooth muscle vasorelaxant responses to exogenous NO differ
between arteries from WT and RPTPg KO mice. In presence of CO2/HCO3
–, spermine NONOate and
S-nitroso-N-acetylpenicillamine (SNAP) produced equivalent vasorelaxation in basilar and mesenteric
arteries from RPTPg KO and WT mice (Figure 5B,C,E,F).
Together, our findings support that RPTPg exerts acute influences on endothelial signaling path-
ways regulating the activity of endothelium-dependent vasorelaxation in response to [HCO3
–]. This
interpretation is in agreement with the near-complete normalization of vasorelaxation observed in
arteries from RPTPg KO mice upon omission of CO2/HCO3
– (Figure 4).
RPTPg enhances endothelial Ca2+ responses with no effect on
intracellular pH
We then determined whether endothelial intracellular Ca2+ signals differ between arteries from
RPTPg KO and WT mice (Figure 5G–N). Loading of isolated arteries with Ca2+-sensitive fluorophores
through luminal perfusion ensured endothelium-specific fluorescence signals (Figure 5G,K).
In the presence of CO2/HCO3
–, application of acetylcholine elevated intracellular [Ca2+] substan-
tially more in endothelial cells of basilar and mesenteric arteries from WT mice than in arteries from
RPTPg KO mice (Figure 5H,J,L,N). In contrast, we saw no significant difference between the intracel-
lular Ca2+ responses of endothelial cells in arteries from WT and RPTPg KO mice when they were
investigated in the nominal absence of CO2/HCO3
– (Figure 5I,J,M,N).
Reduced endothelial intracellular Ca2+ responses in arteries from RPTPg KO mice in presence of
CO2/HCO3
– likely explain the observed mixed attenuation of NO-mediated and EDH-type
Figure 1 continued
The 4-mm-thick longitudinal histological sections illustrate basilar and middle cerebral arteries where the lumen is collapsed, and endothelial cells (EC)
from opposing walls meet at the center and are surrounded by their adjacent tunica media (M). The images are representative of tissue from 4
PtprgLacZ/LacZ mice and 2 WT mice. (B) Ptprg mRNA levels in arteries from WT mice displayed relative to the ribosomal S18 and b-actin reference genes
(n = 11) and normalized to the average level in basilar arteries. (C–E) Single-cell RNA sequencing data analyzed for endothelial Ptprg expression in
healthy murine brain (3482 cells), heart (3219 cells), skeletal muscle (m. soleus, 2457 cells), lung (3972 cells), and small intestine (974 cells). Data are
averaged across each vascular bed (C), displayed as t-SNE plots of Ptprg transcript patterns (left images) and clustered vessel types (right images) (D),
and divided and quantified according to vessel type in each tissue (E). The single-cell RNA sequencing data are from the online EC Atlas database
(Kalucka et al., 2020). Data in panel B were compared after log-transformation using repeated-measures one-way ANOVA followed by Dunnett’s post-
test. *p<0.05, **p<0.01, NS: not significantly different vs basilar arteries.
Hansen et al. eLife 2020;9:e57553. DOI: https://doi.org/10.7554/eLife.57553 5 of 26
Research article Genetics and Genomics Medicine
Figure 2. Acetylcholine (ACh)-induced endothelium-dependent vasorelaxation is compromised in basilar, mesenteric, and coronary arteries from RPTPg
KO mice when investigated in presence of CO2/HCO3
–. (A and D) Force recordings illustrating acetylcholine-induced vasorelaxation of U46619-
contracted basilar arteries under control conditions (A) and after treatment with 100 mM L-NAME (D). The pre-contraction force development in
response to U46619 was normalized in order to display relative relaxations. (B, I, and M) Acetylcholine-induced relaxations of basilar (B, n = 7–9),
Figure 2 continued on next page
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vasorelaxation (Figures 2 and 3) as these responses rely on the Ca2+-sensitive NO-synthase and on
intermediate- (IKCa) and small-conductance (SKCa) Ca
2+-activated K+-channels, respectively
(Figure 5O).
Intracellular H+ and Ca2+ can compete for buffer binding (Batlle et al., 1993), many Ca2+ han-
dling proteins are pH-sensitive (Boedtkjer and Aalkjaer, 2012), and pH is an important regulator of
NO-synthase activity (Boedtkjer et al., 2011). Therefore, we next evaluated whether RPTPg KO
influences intracellular pH—measured using the pH-sensitive fluorophore BCECF—in endothelial
cells of small arteries. In basilar (Figure 5P) as well as mesenteric (Figure 5Q) arteries, intracellular
pH of the endothelial cells was similar for RPTPg KO and WT mice, irrespective of whether experi-
ments were performed with or without CO2/HCO3
–. Omission of CO2/HCO3
– from the bath solutions
had no net effect on endothelial steady-state intracellular pH (Figure 5P,Q), which is consistent with
previous studies based on arteries from C57BL/6 mice (Boedtkjer et al., 2011; Boedtkjer et al.,
2012).
RPTPg amplifies hyperventilation-induced blood pressure elevations
If the vasomotor impact of RPTPg is sufficiently widespread to affect total peripheral resistance, we
predicted that KO of RPTPg would influence blood pressure regulation. We therefore measured sys-
temic blood pressure and heart rate by radiotelemetry (Figure 6A,B). Based on these recordings,
we observed no difference in resting blood pressure or heart rate (Figure 6A) or in the blood pres-
sure-elevating effect of L-NAME (Figure 6B) between RPTPg KO and WT mice.
As the lack of difference in resting blood pressure between WT and RPTPg mice could be due to
compensatory adaptations, we next studied acute blood pressure responses of endotracheally intu-
bated, mechanically ventilated mice under capnographic control. When mice were ventilated to a
normal expiratory end-tidal CO2 fraction (FETCO2) of 3.5%, arterial blood gas parameters were very
similar in RPTPg KO and WT mice (Table 1) consistent with previous findings (Zhou et al., 2016).
Hyperventilating mice until FETCO2 was lowered to 2% caused the expected decrease in PaCO2 and




resulted in the anticipated decrease in [HCO3
–]a (Table 1). The mean arterial blood pressure of WT
mice increased around 20% during hyperventilation and this blood pressure response was reduced
by approximately 1/3 in RPTPg KO mice (Figure 6C). Although the observed hyperventilation-
induced reduction in arterial [HCO3
–] was of modest magnitude (1.4 mM, Table 1), the associated
increase in blood pressure is consistent with attenuated RPTPg-dependent vasodilator influences
when extracellular [HCO3
–] decreases (Boedtkjer et al., 2016c). The remaining hyperventilation-
induced blood pressure elevation likely results from a direct vasocontractile effect of alkalosis
(Boedtkjer et al., 2016c).
RPTPg regulates cerebral perfusion
Metabolic waste products—that are generated at elevated rate and locally accumulate when neuro-
nal activity increases—influence cerebral blood flow. We studied cerebral perfusion using laser
Figure 2 continued
mesenteric (I, n = 11–13), and coronary (M, n = 7) arteries from RPTPg KO and WT mice under control conditions, i.e. without inhibitors of endothelial
function. For mesenteric and coronary arteries, we applied a concentration of 0.5 and 3.0 mM acetylcholine, respectively. (C) Experiment similar to that
in panel B but performed in a CO2/HCO3
–-containing solution without HEPES (n = 9–10). (E, J, and N) Acetylcholine-induced relaxations of basilar (E,
n = 7–9), mesenteric (J, n = 11–13), and coronary (N, n = 7) arteries from RPTPg KO and WT mice after treatment with 100 mM L-NAME. For mesenteric
and coronary arteries, we applied a concentration of 0.5 and 3.0 mM acetylcholine, respectively. (F, K, and O) Acetylcholine-induced L-NAME-sensitive
relaxations of basilar (F, n = 7–9), mesenteric (K, n = 11–13), and coronary (O, n = 7) arteries from RPTPg KO and WT mice calculated as the difference
in relaxations with and without 100 mM L-NAME. For mesenteric and coronary arteries, we applied a concentration of 0.5 and 3.0 mM acetylcholine,
respectively. (G, L, and P) Acetylcholine-induced relaxations of basilar (G, n = 7–9), mesenteric (L, n = 11–13), and coronary (P, n = 7) arteries from
RPTPg KO and WT mice after treatment with 100 mM L-NAME, 50 nM apamin, and 1.0 mM TRAM-34. For mesenteric and coronary arteries, we applied a
concentration of 0.5 and 3.0 mM acetylcholine, respectively. (H) Vascular smooth muscle cell membrane potential responses (DVm) to 3.0 mM
acetylcholine in basilar arteries from RPTPg KO and WT mice in presence of 100 mM L-NAME. Data were compared using two-way ANOVA followed by
Sidak’s post-test (panel B, C, and E-G), non-parametric Mann-Whitney test (panel H, K-M, and O), unpaired two-tailed Student’s t-test (panel I and J) or
unpaired two-tailed t-test with Welch’s correction (panel N and P). Comparisons in panel B and J were made after square root transformation. *p<0.05,
**p<0.01, NS: not significantly different vs WT.
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Figure 3. SLIGRL-amide-induced endothelium-dependent vasorelaxation is compromised in basilar, mesenteric, and coronary arteries from RPTPg KO
mice when investigated in presence of CO2/HCO3
–. (A and D) Force recordings illustrating SLIGRL-amide-induced vasorelaxation of U46619-contracted
basilar arteries under control conditions (A) and after treatment with 100 mM L-NAME (D). The numbers indicate points of cumulative stepwise increases
in SLIGRL-amide from 0.1 mM to 10.0 mM. WO indicates the point of washout. The pre-contraction force development in response to U46619 was
normalized in order to display relative relaxations. (B, I, and L) SLIGRL-amide-induced relaxations of basilar (B, n = 12), mesenteric (I, n = 11), and
Figure 3 continued on next page
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speckle imaging (Figure 6D–F) in order to evaluate the involvement of RPTPg in sensing of acid-
base disturbances. Tissue perfusion in the somatosensory barrel cortex increased twice as much in
RPTPg KO mice compared to WT mice during whisker stimulation (Figure 6E). This finding is consis-
tent with metabolically produced H+ leading to a local decrease in [HCO3
–] that is sensed via RPTPg
in arteries from WT mice (Figure 5O). As RPTPg-dependent vasorelaxation wanes at low [HCO3
–]
(Boedtkjer et al., 2016c), our data support that RPTPg limits increases in cerebral perfusion induced
by metabolic acidosis (Figure 6E).
Acid-base conditions during increased neuronal activity are complicated, as the increased metab-
olism will also induce some degree of CO2 accumulation that tends to increase [HCO3
–]. In order to
produce a simpler acid-base disturbance with predictable changes in extracellular [HCO3
–], we next
hyperventilated mice, which reduced pCO2, increased pH, and lowered [HCO3
–] (Table 1). Under
these conditions, cerebral vasoconstriction is expected in WT mice based on the combined effect of
alkalosis and decreased [HCO3
–] (Boedtkjer et al., 2016c). If RPTPg is required for sensing of HCO3
–,
only the effect of the elevated pH is expected in the RPTPg KO mice; and indeed, we saw a 30%
smaller drop in cerebral perfusion in RPTPg KO mice compared to WT mice during hyperventilation
(Figure 6F). These recordings may in fact underestimate the difference in cerebrovascular resistance
between RPTPg KO and WT mice since the cerebral perfusion pressure—based on the blood pres-
sure changes shown in (Figure 6C)—increased less in hyperventilated RPTPg KO than WT mice.
When whisker stimulation was performed during hyperventilation, we saw an even more prominent
difference in cerebral perfusion between WT and RPTPg KO mice (Figure 6F).
Together, our findings demonstrate that RPTPg plays a substantial role for control of blood pres-
sure (Figure 6C) and cerebral perfusion (Figure 6E,F) during acid-base deviations where [HCO3
–]
decreases below the normal level.
PTPRG is a susceptibility locus for ischemic vascular disease
Based on human exome sequencing data from the UK Biobank, we next explored whether the func-
tional role of RPTPg in regulating endothelial function and responding to metabolic disturbances in
murine cerebral, mesenteric, and coronary arteries is corroborated by and translates to an altered
risk for human ischemic vascular disease amongst carriers of predicted loss-of-function variants
within PTPRG. We identified 334 missense variants and 75 predicted loss-of-function variants (cate-
gorized as low, moderate, and high impact) in PTPRG among the ~50,000 UK Biobank participants
with available exome sequencing data.
The 72 carriers of predicted loss-of-function PTPRG variants with moderate or high impact
showed substantially elevated risk (Figure 7A) of a combined vascular disease phenotype encom-
passing the three vascular beds functionally investigated in this study (Figures 2–6): cerebral infarct
(ICD-10 diagnosis code I63), angina pectoris (ICD-10 diagnosis code I20), acute myocardial infarction
(ICD-10 diagnosis code I21), and acute vascular disorders of the intestine (ICD-10 diagnosis code
K55.0). In contrast, the 123 carriers of predicted loss-of-function PTPRG variants with low impact as
well as the 29,975 carriers of one or more missense PTPRG variants had a risk similar to non-carriers
for this aggregated phenotype of acute vascular disease (Figure 7A).
We followed-up by investigating the separate occurrences of diagnosed angina pectoris, acute
myocardial infarction, and cerebral infarction amongst the individuals, who carried a predicted loss-
of-function variant with moderate or high impact. The carriers of these most severe loss-of-function
Figure 3 continued
coronary (L, n = 7) arteries from RPTPg KO and WT mice under control conditions, that is without inhibitors of endothelial function. (C) Experiment
similar to that in panel B but performed in a CO2/HCO3
–-containing solution without HEPES (n = 8). (E, J, M) SLIGRL-amide-induced relaxations of
basilar (E, n = 12), mesenteric (J, n = 11), and coronary (M, n = 7) arteries from WT and RPTPg KO mice after treatment with 100 mM L-NAME alone or in
combination with 50 nM apamin and 1.0 mM TRAM-34. (F, K, and N) SLIGRL-amide-induced L-NAME-sensitive relaxations of basilar (F, n = 12),
mesenteric (K, n = 11), and coronary (N, n = 7) arteries from RPTPg KO and WT mice calculated as the difference in area under the curve (AUC)
between the concentration-response curves with and without L-NAME. (G and H) Original recordings (G) and summarized data (H, n = 8–9) from basilar
arteries showing vascular smooth muscle cell membrane potential (Vm) responses to SLIGRL-amide in presence of 100 mM L-NAME. In panel B, C, E, I,
J, L, and M, the relative relaxations were fitted to sigmoidal curves and compared using extra sum-of-squares F tests. In panel F, K, and N, the relative
relaxations were compared by unpaired two-tailed Student’s t-test. In panel H, membrane potential responses were compared by two-way ANOVA
followed by Sidak’s post-test. *p<0.05, **p<0.01, ***p<0.001. NS: not significantly different vs WT.
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Figure 4. In absence of CO2/HCO3
–, acetylcholine (ACh)- and SLIGRL-amide-induced endothelium-dependent vasorelaxation of basilar and mesenteric
arteries is similar between RPTPg KO and WT mice. (A and C) Force recordings illustrating acetylcholine-induced vasorelaxation of U46619-contracted
basilar arteries under control conditions (A) and after treatment with 100 mM L-NAME (C). The pre-contraction force development in response to
U46619 was normalized in order to display relative relaxations. (B and G) Acetylcholine-induced relaxations of basilar (B, n = 11) and mesenteric (G,
Figure 4 continued on next page
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variants had dramatically increased risk (~7 fold) of cerebral infarction whereas the risk of acute myo-
cardial infarction showed a tendency toward elevation that did not reach statistical significance
(Figure 7B). The number of exome-sequenced UK Biobank participants with acute intestinal vascular
disease was too low to provide statistical power for a separate analysis.
To complement the evidence based on ICD-10 diagnosis codes, we further evaluated whether
carriers of missense and loss-of-function variants in PTPRG differed in self-reported diseases com-
pared to non-carriers (Figure 7C). The risk of self-reported heart attacks was greatly elevated (~4
fold) amongst individuals carrying loss-of-function PTPRG variants of moderate and high impact
(Figure 7C). The risk of self-reported stroke also showed a strong tendency toward elevation—with
borderline statistical significance—amongst the carriers of moderate- and high-impact loss-of-func-
tion PTPRG variants (Figure 7C).
As cardiac pumping function often deteriorates following coronary ischemia, we next evaluated
the cardiac contractile function in PTPRG loss-of-function carriers amongst the 12,851 exome-
sequenced UK Biobank participants with available cardiac magnetic resonance imaging (MRI) data.
We observed a significantly lower left ventricular ejection fraction in carriers of high-impact loss-of-
function PTPRG variants compared to non-carriers (Figure 7D) consistent with the greater risk of
ischemic heart disease (Figure 7C).
The statistical analyses linking PTPRG to risk of ischemic vascular disease (Figure 7A–C) and
reduced left ventricular ejection fraction (Figure 7D) were all adjusted for sex, age, body mass index,
genetic principal component, smoking status, dyslipidemia, diabetes, and hypertension between car-
riers and non-carriers of the evaluated PTPRG variants.
Taken together, we demonstrate that RPTPg (a) CO2/HCO3
–-dependently enhances endothelial
intracellular Ca2+ responses and endothelium-dependent vasorelaxation, (b) regulates microvascular
perfusion and blood pressure during acid-base disturbances, and (c) is associated with human ische-
mic vascular disease of the brain and heart.
Discussion
Local acid-base-dependent mechanisms of arterial tone regulation match tissue perfusion to the oxi-
dative metabolic demand and thereby dynamically control cardiovascular function during cycles of
intermittent rest and activity. Re-establishing proper tissue perfusion is of obvious clinical importance
when managing patients with latent or fulminant ischemia. Responses of coronary and cerebral arter-
ies to acid-base disturbances have been recognized for almost 140 years (Gaskell, 1880; Las-
sen, 1968) but this information has not yet been harnessed for therapeutic intervention for lack of
identified molecular players and their interactions. In the current study, we identify PTPRG as a sus-
ceptibility locus for human ischemic vascular disease (Figure 7) and provide mechanistic evidence
Figure 4 continued
n = 6–7) arteries from RPTPg KO and WT mice under control CO2/HCO3
–-free conditions, that is, without inhibitors of endothelial function. (D and H)
Acetylcholine-induced relaxations of basilar (D, n = 11) and mesenteric (H, n = 6–7) arteries from RPTPg KO and WT mice in presence of 100 mM
L-NAME under CO2/HCO3
–-free conditions. (E and I) Acetylcholine-induced L-NAME-sensitive relaxations of basilar (E, n = 11) and mesenteric (I, n = 6–
7) arteries from RPTPg KO and WT mice calculated as the difference between relaxations with and without L-NAME. Experiments were performed in
absence of CO2/HCO3
–. (F and J) Acetylcholine-induced relaxations of basilar (F, n = 11) and mesenteric (J, n = 6–7) arteries from RPTPg KO and WT
mice after treatment with 100 mM L-NAME, 50 nM apamin, and 1.0 mM TRAM-34 under CO2/HCO3
–-free conditions. (K and M) Force recordings
illustrating SLIGRL-amide-induced vasorelaxation of U46619-contracted basilar arteries under control conditions (K) and after treatment with 100 mM
L-NAME (M). The numbers indicate points of cumulative stepwise increases in SLIGRL-amide from 0.1 mM to 10.0 mM. WO indicates the point of
washout. The pre-contraction force development in response to U46619 was normalized in order to display relative relaxations. (L and P) SLIGRL-amide-
induced relaxations of basilar (L, n = 10) and mesenteric (P, n = 6–7) arteries from RPTPg KO and WT mice under control CO2/HCO3
–-free conditions,
that is, without inhibitors of endothelial function. (N and Q) SLIGRL-amide-induced relaxations of basilar (N, n = 10) and mesenteric (Q, n = 6–7) arteries
from RPTPg KO and WT mice after treatment with 100 mM L-NAME alone or in combination with 50 nM apamin and 1.0 mM TRAM-34. The experiments
were performed in absence of CO2/HCO3
–. (O and R) SLIGRL-amide-induced L-NAME-sensitive relaxations of basilar (O, n = 10) and mesenteric (R,
n = 6–7) arteries from RPTPg KO and WT mice calculated as the difference in area under the curve (AUC) between the concentration-response curves
with and without L-NAME. In panels A-J, we applied a concentration of 0.5 mM acetylcholine. Data in panels B, E, G-J, and O were compared by
unpaired two-tailed Student’s t-tests, data in panels D and R by non-parametric Mann-Whitney test, and data in panel F by unpaired two-tailed t-test
with Welch’s correction. In panels L, N, P, and Q, the relative relaxations were fitted to sigmoidal curves and compared using extra sum-of-squares F
tests. Data in panel J were log-transformed before comparison. **p<0.01, NS: not significantly different vs WT.
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Figure 5. Acetylcholine (ACh)-induced endothelial intracellular Ca2+ responses are lower in arteries from RPTPg KO than WT mice. In contrast,
expression of endothelial NO-synthase (eNOS), responses to NO-donors, and endothelial intracellular pH are unaffected in basilar and mesenteric
arteries from RPTPg KO compared to WT mice. (A and D). Expression of eNOS in basilar (A) and mesenteric (D) arteries from RPTPg KO and WT mice
(n = 5–6). Representative bands are shown next to results from densitometric analyses where the expression levels relative to pan-actin are normalized
Figure 5 continued on next page
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that RPTPg regulates endothelial intracellular Ca2+ responses (Figure 5H,L), endothelium-dependent
vasorelaxation (Figures 2 and 3), cerebral perfusion (Figure 6E,F), and blood pressure (Figure 6C)
during acid-base disturbances and increased metabolic demand.
Variation in buffer composition accompanies changes in pH during acid-base disturbances. We
show that the CO2/HCO3
– buffer plays a hitherto unappreciated role for regulation of endothelial
function and arterial tone through mechanisms that require RPTPg (Figures 2–4). As schematically
illustrated in Figure 5O, we demonstrate that RPTPg enhances endothelial intracellular Ca2+ signals
(Figure 5G–N) that in turn activate endothelial NO synthesis and EDH-type responses (Figures 2
and 3). These effects are in congruence with the Ca2+-sensitivity of eNOS and the SK and IK Ca2+-
activated K+-channels. The vasorelaxant influence of RPTPg wanes at low extracellular [HCO3
–]
(Boedtkjer et al., 2016c), which attenuates by half the elevation of cerebral perfusion during sensory
input (Figure 6E) and amplifies by 30% the decrease in perfusion during hyperventilation
(Figure 6F). We also observe that RPTPg is necessary for approximately 1/3 of the blood pressure
increase during hyperventilation (Table 1 and Figure 6C). Considering the prominent influence of
RPTPg on endothelial function in several vascular beds, somewhat surprisingly, we observe blood
pressure consequences of RPTPg KO only when we impose acute acid-base disturbances
(Figure 6A–C). The unaltered resting blood pressure in RPTPg KO mice (Figure 6A) most likely
reflects that numerous discrete mechanisms are involved in blood pressure control and that compen-
sation—for example, through nervous, hormonal or renal influences (Boedtkjer and Aalkjaer,
2013b)—can maintain blood pressure in the sustained phase and mask hemodynamic consequences
of RPTPg except when acute acid-base disturbances are imposed.
Previously recognized cellular acid-base sensors include G-protein coupled receptors (e.g. OGR1,
GPR4, and TDAG8), ion channels (e.g. ASIC, BKCa), and enzymes (e.g. NO-synthase and rho-kinase)
sensitive to H+ (Boedtkjer et al., 2011; Boedtkjer et al., 2012; Fleming et al., 1994;
Schubert et al., 2001; Ludwig et al., 2003; Wemmie et al., 2006; Wenzel et al., 2020). In addition,
we and others have described cellular functions responsive to changes in [HCO3
–] and modified by
RPTPg (Zhou et al., 2016; Boedtkjer et al., 2016c) or the soluble adenylyl cyclase (Chen et al.,
2000). Evidence connecting acid-base sensors to human disease has so far been scarce; but in the
current study, we identify PTPRG as an ischemia susceptibility locus (Figure 7), which is supported
by a recent meta-analysis of genome-wide association studies linking PTPRG to ischemic stroke in
African Americans (Carty et al., 2015).
Using out-of-equilibrium technology—that permits separate control of pH and the individual
CO2/HCO3
– buffer components—we previously demonstrated that RPTPg responds to changes in
extracellular [HCO3
–] independently of pCO2 and pH (Boedtkjer et al., 2016c). The homology
between the extracellular domain of RPTPg and the active site of the carbonic anhydrases supports
the ability of RPTPg to bind HCO3
– even though it lacks histidine residues required for carbonic anhy-
drase activity (Zhou et al., 2016). The intracellular aspect of RPTPg contains phosphatase domains
Figure 5 continued
to the average level in arteries from WT mice. (B and E) Spermine NONOate-induced relaxations of basilar (B, n = 10–14) and mesenteric (E, n = 9)
arteries from RPTPg KO and WT mice. (C and F) SNAP-induced relaxations of basilar (C, n = 10–15) and mesenteric (F, n = 9) arteries from RPTPg KO
and WT mice. All experiments in panels B, C, E, and F were performed on arteries pre-contracted with U46619, in presence of CO2/HCO3
–, and after
treatment with 100 mM L-NAME, 50 nM apamin, and 1.0 mM TRAM-34. (G and K) Overlaid fluorescence images of endothelial cells in basilar (G) and
mesenteric (K) arteries loaded by luminal perfusion with Fluo-4 (green) and Fura Red (red). (H, I, L, and M) Average traces of acetylcholine-induced
endothelial intracellular Ca2+ responses in basilar (H and I) and mesenteric (L and M) arteries from RPTPg KO and WT mice (n = 6–9) in presence
(H and L) and absence (I and M) of CO2/HCO3
–. The evaluation of endothelial Ca2+ responses was based on the F505-530/F>600 ratio normalized to the
average ratio during the first two minutes of the individual recordings. (J and N) Summarized endothelial intracellular Ca2+ responses in basilar (J) and
mesenteric (N) arteries upon acetylcholine stimulation (n = 6–9). The endothelial Ca2+ response was calculated as the average increase in normalized
fluorescence during the 2 min acetylcholine exposure compared to the baseline value before activation. (O) Schematic illustration of how RPTPg
influences vasomotor functions of resistance arteries. (P and Q) Steady-state intracellular pH of endothelial cells in basilar (P) and mesenteric (Q) arteries
from RPTPg KO and WT mice (n = 5–7) in the presence and absence of CO2/HCO3
–. In panels A and D, expression levels were compared with unpaired
two-tailed Student’s t-tests. In panels B, C, E, and F, the relative relaxations were fitted to sigmoidal curves and compared using extra sum-of-squares F
tests. In panels J and N, data were compared by two-way ANOVA followed by Sidak’s post-tests. In panels P and Q, data were compared by repeated-
measures two-way ANOVA followed by Sidak’s post-tests. The data in panel N were log-transformed before comparisons. *p<0.05, **p<0.01,
***p<0.001, NS: not significantly different vs WT. ER, endoplasmic reticulum; Kir, inward-rectifier K
+-channel; IKCa, intermediate-conductance K
+-
channel; NOS, NO-synthase; SKCa, small-conductance K
+-channel; SNAP, S-nitroso-N-acetylpenicillamine.
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Figure 6. Systemic blood pressure and heart rate are similar in WT and RPTPg KO mice at rest. In contrast, RPTPg KO mice show elevated
cerebrovascular perfusion during whisker stimulation, attenuated hyperventilation-induced blood pressure elevation, and diminished hyperventilation-
induced reduction in cerebrovascular perfusion. (A) Resting mean arterial pressure (MAP) and heart rate (HR) measured by radiotelemetry in WT and
RPTPg KO mice (n = 6–7). Data were compared by unpaired two-tailed Student’s t-tests. (B) Mean arterial pressure under control conditions and during
intake of 100 and 600 mg/kg/day L-NAME in the drinking water (n = 4–5). Data were square root-transformed and then compared by repeated-
measures two-way ANOVA. (C) Changes in relative mean arterial blood pressure (DMAP, solid lines) and expiratory end-tidal CO2 fraction (FETCO2,
dashed lines) during hyperventilation (n = 13). The steady-state values averaged over the last 30 s of the stimulation period were compared between
WT and RPTPg KO mice by unpaired two-tailed Student’s t-test (DMAP) or non-parametric Mann-Whitney test (FETCO2). In the anesthetized mice, the
absolute mean arterial blood pressure prior to hyperventilation was 63 ± 5 mmHg in RPTPg KO compared to 60 ± 3 mmHg in WT mice (p=0.63,
unpaired two-tailed Student’s t-test). (D) Exemplar laser speckle images. The left image shows the second posterior bifurcation of the middle cerebral
artery (arrows) that was used to locate the same region of interest (dotted square) in each experiment. The right image provides a 7.5% threshold
response map from a whisker stimulation experiment in an RPTPg KO mouse. (E and F) Relative cerebrovascular perfusion in the barrel cortex (dotted
square in panel D) of RPTPg KO and WT mice during whisker stimulation (E, n = 9) and during hyperventilation alone or combined with whisker
stimulation (F, n = 8). The steady-state blood flow index averaged over the last minute of the intervention period was compared between WT and
Figure 6 continued on next page
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with suggested auto-inhibitory activity; and HCO3
– possibly alters the phosphatase activity by influ-
encing the degree of RPTPg dimerization (Barr et al., 2009). The separate signaling effects of H+
and HCO3
– are further confirmed by the similar steady-state intracellular pH of endothelial cells in
arteries from WT and RPTPg KO mice (Figure 5P,Q).
The current study adds to our growing appreciation that acid-base equivalents, and HCO3
– in par-
ticular, fulfill multifaceted functions (Boedtkjer et al., 2016a). In cerebral resistance arteries, HCO3
–
(a) contributes to buffering of acute acid loads (Rasmussen and Boedtkjer, 2018), (b) serves as sub-
strate particularly for the Na+,HCO3
–-cotransporter NBCn1 that protects against intracellular acidifi-
cation (Thomsen et al., 2014), and (c) is sensed by RPTPg to regulate cerebral perfusion (Figure 6).
In migrating vascular smooth muscle cells from conduit arteries, the high spatial mobility of the CO2/
HCO3
– buffer system also contributes to dissipating local pH gradients in diffusion-restricted spaces
of filopodia (Boedtkjer et al., 2016b).
Our current (Figures 1–4 and 6) and previous (Boedtkjer et al., 2016c) findings demonstrate
that the endothelium of resistance arteries senses the local acid-base composition and has capacity
to modify vascular resistance and perfusion in response to disturbances in extracellular [HCO3
–]. Ear-
lier studies of mouse arteries provide additional evidence that intracellular acidification inhibits endo-
thelial NO-synthesis (Boedtkjer et al., 2011; Boedtkjer et al., 2012; Thomsen et al., 2014),
intracellular alkalinisation interferes with myo-endothelial current transfer required for EDH-type
responses (Boedtkjer et al., 2013a), and acid-base disturbances modify prostanoid-mediated endo-
thelium-dependent vasocontraction (Baretella et al., 2014). Together, these studies highlight the
sophisticated nature of vasomotor control that integrate the requirement for local blood flow and
the necessity to minimize deviations in capillary pressure and fluid filtration during local metabolic
disturbances, perturbed nutrient delivery, and restricted waste product elimination. Acting as a
brake on vasodilation in regions of unmet metabolic demand, RPTPg could reduce the degree of
edema and consequent tissue damage caused by unopposed H+-induced vasodilation
(Boedtkjer, 2018; Boedtkjer et al., 2016a).
As illustrated in Figure 1D and E, Ptprg mRNA is found in arteriolar, capillary, as well as venular
endothelial cells (Kalucka et al., 2020; Vanlandewijck et al., 2018), and it remains a future task to
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RPTPg KO mice by unpaired two-tailed Student’s t-test (whisker stimulation) or unpaired two-tailed t-test with Welch’s correction (hyperventilation).
*p<0.05, **p<0.01, NS: not significantly different vs WT. FETCO2 indicates the expiratory end-tidal CO2 fraction measured by capnography.
Table 1. Arterial blood gas measurements from RPTPg KO and WT mice (n = 7–9) under control conditions (normoventilation,
FETCO2 = 3.5%) and after 2 min of hyperventilation (FETCO2 = 2%).
We compared data by repeated-measures two-way ANOVA. FETCO2, expiratory end-tidal CO2 fraction.
Arterial blood gasses WT RPTPg KO
Control, FETCO2 = 3.5%
pHa 7.28 ± 0.01 7.28 ± 0.01
PaCO2 (mmHg) 45.2 ± 1.2 46.2 ± 1.8
[HCO3
–]a (mM) 20.4 ± 0.6 20.9 ± 0.8
Hyperventilation, FETCO2 = 2%
pHa 7.38 ± 0.02 7.41 ± 0.01
PaCO2 (mmHg) 32.3 ± 0.9 32.3 ± 1.5
[HCO3
–]a (mM) 19.0 ± 0.9 19.2 ± 0.8
Statistics (repeated-measures two-way ANOVA) p-Values
Genotype Ventilation Interaction
pHa 0.40 <0.001 0.19
PaCO2 0.90 <0.001 0.06
[HCO3
–]a 0.69 <0.001 0.47
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Figure 7. Burden analysis of loss-of-function variants in PTPRG reveals association with human ischemic vascular
disease. (A) Association of PTPRG missense variants (localized outside exon-intron boundary regions) and
predicted loss-of-function (LOF) variants of low, moderate, and high impact with ischemic cerebral, coronary, and
mesenteric vascular disease (aggregate of ICD-10 diagnosis codes I20, I21, I63, and K55.0). (B and C) Association
Figure 7 continued on next page
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evaluate physiological and pathophysiological roles of RPTPg in these individual blood vessel seg-
ments. Transcript levels for Ptprg appear particularly high in a smaller subset of endothelial cells (up
to 20–40%, depending on the vascular bed; Figure 1C–E), which raises the intriguing possibility that
a distinct population of endothelial cells act as the primary sensors of the metabolic environment.
Hyperventilation-induced cerebral vasoconstriction can cause syncope but is also a therapeutic
tool for rapidly reducing cerebral blood flow, capillary filtration, and intracranial pressure. Hypocap-
nia during hyperventilation leads to decreased [HCO3
–] and alkalosis (Table 1); and the current study
demonstrates that RPTPg is necessary for approximately 30% of the associated decrease in cerebral
perfusion (Figure 6F).
In conclusion, the single-pass transmembrane protein RPTPg enhances endothelium-dependent
vasorelaxation of resistance arteries—by amplifying endothelial intracellular Ca2+ responses, NO syn-
thesis, and EDH-type responses—and adjusts cerebral perfusion during increased neuronal activity
and acid-base disturbances. Although RPTPg shows no major impact on resting blood pressure, it
contributes markedly to the blood pressure increase observed during hyperventilation. Supporting
the translational value of our findings, predicted loss-of-function variants in PTPRG are associated
with human ischemic vascular disease in the brain and heart. The influence of RPTPg on vascular
resistance specifically in tissues with disturbed acid-base composition makes RPTPg a promising
focus for targeted therapeutic intervention against ischemia.
Materials and methods
RPTPg KO mice (MGI:3663183) from Dr. Joseph Schlessinger, Yale University, USA
(Lamprianou et al., 2006), were kindly provided by Dr. Walter F. Boron, Case Western Reserve Uni-
versity, USA (Zhou et al., 2016). The transgenic mice were originally generated by inserting an inter-
nal ribosome entry site–b-galactosidase–neomycin–poly(A) cassette immediately 3’ of exon 1
(Lamprianou et al., 2006). Homologous recombination in W4 129S6/SvEv mouse embryonic stem
cells (RRID:CVCL_Y634) was achieved following electroporation, and correctly targeted embryonic
stem cells were used for embryo aggregation to achieve germ line chimeras (Lamprianou et al.,
2006). At the time of experiments, the transgene-carrying mice had been backcrossed to the
C57BL/6 line for at least eight generations. In total, we used 125 WT and 112 RPTPg KO mice that
were kept on a 12 hr light/12 hr dark cycle with ad libitum access to tap water and chow (Altromin
1324; Brogaarden, Danmark). We used Eco-Pure Aspen Chips 2 Premium cage bedding (Datesand,
UK). Genomic DNA used for genotyping was isolated from tail biopsies collected at weening and
again after sacrifice. All animal experimental procedures were approved by the Danish Animal
Experiments Inspectorate (2016-15-0201-00982).
Small vessel myography
Male RPTPg KO and matched WT mice (>8 weeks old) deeply anesthetized by intraperitoneal injec-
tion of pentobarbital were sacrificed by exsanguination. Approximately 2 mm long segments of basi-
lar, mesenteric, and coronary septal arteries were dissected under a stereomicroscope, mounted in
four-channel wire myographs (610M; DMT, Denmark) for isometric investigation, heated to 37˚C,
and normalized to 90% of the internal diameter corresponding to a transmural pressure of 100
mmHg (Mulvany and Halpern, 1977). The myograph chambers were aerated with 5% CO2/balance
air (for CO2/HCO3
–-containing physiological saline solutions) or nominally CO2-free air (for CO2/
HCO3
–-free solutions). The CO2/HCO3
–-containing solution consisted of (in mM): 119 NaCl, 22
NaHCO3, 10 HEPES, 1.2 MgSO4, 2.82 KCl, 5.5 glucose, 1.18 KH2PO4, 0.03 EDTA, 1.6 CaCl2. The
CO2/HCO3
–-free solution was produced by substituting NaHCO3 with NaCl. HEPES is necessary for
pH control in the CO2/HCO3
–-free solution; and we included HEPES also in the CO2/HCO3
–-containing
Figure 7 continued
of predicted moderate- and high-impact loss-of-function variants in PTPRG with diagnosed (B) and self-reported
(C) coronary and cerebral ischemia. (D) Association between missense and loss-of-function variants in PTPRG and
left ventricular ejection fraction. The p-values in panel A through C come from logistic regression analyses and the
p-values in panel D from multiple linear regression analyses. In each case, we adjusted for sex, age, body mass
index, genetic principal component, smoking status, dyslipidemia, diabetes, and hypertension.
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solution in order to separate vascular effects of CO2/HCO3
– omission from potential effects of adding
HEPES (Altura et al., 1980). For the control experiments in Figures 2C and 3C, we used a CO2/
HCO3
–-containing solution without HEPES, i.e., where the 10 mM HEPES was substituted with 5 mM
NaCl. After all contents were added, the solutions were vigorously bobbled with the appropriate
CO2-containing or nominally CO2-free gas mixture at 37˚C before pH was adjusted to 7.40 while
allowing ample time for buffer equilibration. Arterial force was acquired using a PowerLab 4/25
recorder and LabChart 7 Pro software (RRID:SCR_001620; ADInstruments, New Zealand). As stan-
dard warm-up protocol, arteries were exposed twice to 3 mM of the thromboxane A2 analog U46619
for 2 min, and arteries that produced less than 1 mN force were excluded from further analysis. Vas-
orelaxation in response to acetylcholine, the PAR2 agonist SLIGRL-amide, and the NO-donors
SNAP, and spermine NONOate was tested in U46619-contracted arteries that developed stable ten-
sion equivalent to ~70% of the maximal response during the standard warm-up procedure. Vasore-
laxation, from the pre-contraction level, was quantified as the relative decrease in active tone during
the last 30 s of each 2 min agonist application. We used two NO donors that differ, for instance, in
their rate and location of NO release (Bradley and Steinert, 2015). Because acetylcholine-induced
vasorelaxation shows substantial tachyphylaxis in arteries from C57BL/6 mice, we tested single doses
of acetylcholine applied on separate U46619 pre-contractions. In contrast, SLIGRL-amide does not
show this degree of tachyphylaxis, and we therefore tested its vasorelaxant properties through
cumulative additions.
Endothelial Ca2+ measurements
Ca2+-sensitive fluorophores were loaded preferentially into endothelial cells by slow (~1 mL/hr for 45
min) perfusion of physiological saline solution containing 2.5 mM Fluo-4 and 3.5 mM Fura Red (Invitro-
gen) through the lumen of basilar and mesenteric arteries mounted in a pressure myograph (120CP;
DMT) (Boedtkjer et al., 2011). The cell permeant acetoxymethyl ester (AM) forms of the fluoro-
phores were first solubilized in a load mix containing dimethyl sulfoxide, Pluronic F127, and Cremo-
phor EL. The loaded arteries were next mounted in a confocal wire myograph (360CW; DMT) and
studied using a Zeiss Axiovert 200M confocal microscope equipped with an LSM Pascal exciter and
a 40  objective (LD C-Apochromat; N.A. 1.10; Zeiss, Germany). The arteries were excited at 488
nm and emission light collected at wavelengths in the range of 505–530 nm (F505-530; representing
Fluo-4 signals that increase at elevated [Ca2+]) and longer than 600 nm (F>600; representing Fura Red
signals that decrease at elevated [Ca2+]). Arteries with no or only solitary loaded endothelial cells
were excluded from analysis. The F505-530/F>600 ratio normalized to the baseline ratio (the first 2 min
of the recording) was used to evaluate relative intracellular Ca2+ dynamics.
Endothelial intracellular pH measurements
Inverted basilar and mesenteric arteries were mounted on a 40 mm wire in a confocal wire myograph
(360CW, DMT) and loaded with the pH-sensitive fluorophore 2’,7’-bis-(2-carboxyethyl) 5-(and-6)-
carboxyfluorescein (BCECF) in physiological saline solution (1 mM BCECF-AM in 0.05‰ DMSO) to
preferentially load endothelial cells, essentially as previously described (Boedtkjer et al., 2011;
Boedtkjer and Aalkjaer, 2009). The loaded arteries were studied using an Olympus IX83 micro-
scope equipped with a 20  objective (LUCPlanFLN; N.A. 0.45; Olympus, Japan) and an ORCA-Flash
4.0 camera (Hamamatsu, Japan). The arteries were alternatingly excited at 490 and 436 nm and
emission light collected at 530 nm. The F490/F436 fluorescence ratio was calibrated to intracellular pH
using the high-[K+] nigericin method (Boedtkjer and Aalkjaer, 2009; Aalkjaer and Cragoe, 1988),
which in arteries agrees well with the null-point technique (Danielsen et al., 2013). Steady-state
intracellular pH was recorded in the presence and absence of CO2/HCO3
–.
Membrane potential recordings
Membrane potentials were measured in vascular smooth muscle cells of isolated basilar arteries
using sharp electrodes as previously described (Boedtkjer et al., 2013a). The arteries were mounted
in a wire myograph (420A; DMT) and microelectrodes that had resistances of 40–120 MW when
backfilled with 3 M KCl were inserted into the vascular wall from the adventitial side. Cell impale-
ment was observed as a sudden drop in voltage followed by sharp return to baseline upon
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retraction. Measurements with more than 10 mV difference between the baseline recording before
and after impalement were excluded from analysis.
LacZ reporter studies
The genetic insert that disrupts RPTPg expression in the employed KO mice contains a promotorless
LacZ sequence allowing for b-galactosidase expression under control of the Ptprg promotor
(Lamprianou et al., 2006). Four homozygous KO mice (PtprgLacZ/LacZ) and two WT mice were perfu-
sion fixed with 4% (weight/volume) paraformaldehyde in phosphate-buffered saline (PBS, in mM:
137 NaCl, 2.5 KCl, 4.3 Na2HPO4, and 1 KH2PO4) and investigated for promoter activity essentially as
previously described (Boedtkjer et al., 2008). Segments of basilar, middle cerebral, gracilis, coro-
nary, mesenteric, and pulmonary arteries as well as thoracic aorta were dissected free from sur-
rounding tissue and washed in PBS overnight at 4˚C. The arteries were then placed in staining
solution (in mM: 5 K4Fe(CN)6, 5 K3Fe(CN)6, 2 MgCl2, 0.1% (weight/volume) sodium dodecyl sulfate
(SDS), 0.1% (volume/volume) TWEEN 20, and 0.1% (weight/volume) 5-bromo-4-chloro-indolyl-13-D-
galactoside (X-Gal)) for 24 hr at room temperature (~21˚C). Finally, samples were transferred to PBS
containing 1% (weight/volume) ethylenediaminetetraacetic acid (EDTA) and 4% paraformaldehyde in
order to stop the staining reaction. Whole mount micrographs of the arteries were captured using a
Leica M165 C stereomicroscope equipped with a Leica M170 HD camera (Germany). In addition, we
paraffin-embedded and cut basilar and middle cerebral arteries—that showed the strongest stain-
ing—to 4-mm-thick histological sections that were visualized on an upright Leica DM light micro-
scope equipped with a Leica DM300 digital camera in order to identify the cellular expression
pattern.
Reverse transcription and quantitative polymerase chain reaction
Arteries dissected free from surrounding tissue in cold physiological saline solution were stored in
RNALater (Qiagen, Denmark) at 4˚C. The isolated arteries were homogenized in RLT lysis buffer (Qia-
gen) using a TissueLyser II (Qiagen) at 30 Hz for 2 min. RNA was isolated using the RNeasy Micro
Qiacube kit including carrier RNA (Qiagen). Samples were reverse transcribed using random deca-
mer primers and Superscript III Reverse Transcriptase (Invitrogen, Fisher Scientific, Denmark). Reac-
tions without reverse transcriptase were performed in order to test for genomic amplification.
Quantitative PCR was performed on an MX3000P system (Agilent, USA) based on Maxima Hot Start
Taq DNA polymerase (ThermoFisher, Denmark). Ptprg mRNA levels relative to the reference genes
Rn18s (18S ribosomal subunit) and Actb (b-actin) were evaluated in the different vascular beds based
on the 2–DDCT method (Livak and Schmittgen, 2001). We used the following forward (F) and reverse
(R) primers and probes (P) purchased from Eurofins Genomics (Germany): Ptprg (F: 5’ TGG TTA
CAA CAA AGC GAA AGC CT 3’, R: 5’ ATA CTG ATC ACA CTT TCT CCT TCC 3’, P: 5’ ATC TGG
GAA CAA AAC ACG GGA ATC ATC AT 3’), Rn18s (F: 5’ AAT AGC CTT CGC CAT CAC TGC 3’, R:
5’ GTG AGG TCG ATG TCT GCT TTC C 3’, P: 5’ TGG GGC GGA GAT ATG CTC ATG TGG TGT T
3’), and Actb (F: 5’ TGA CGT TGA CAT CCG TAA AG 3’, R: 5’ CTG GAA GGT GGA CAG TGA GG
3’ and P: 5’ AGT GCT GTC TGG TGG TAC CAC CAT GTA CC 3’). Probes were modified with 5’ 6-
FAM and 3’ TAMRA. Each reaction consisted of 10 min at 95˚C followed by 50 cycles of 30 s at 95˚C,
60 s at 55˚C, and 60 s at 72˚C.
Single-cell RNA sequencing data
We explored levels of Ptprg transcripts in individual endothelial cells based on the EC Atlas data-
base from VIB-KU Leuven, which is accessible at https://endotheliomics.shinyapps.io/ec_atlas/
(downloaded on 11 June 2020). This online database includes data from a recent single-cell RNA
sequencing study on endothelial cells from healthy mice (Kalucka et al., 2020).
Immunoblotting
We determined protein expression levels of eNOS in basilar and mesenteric arteries by immunoblot-
ting using previously described antibodies (Boedtkjer et al., 2011; Voss et al., 2019). Arteries were
snap frozen in liquid nitrogen and then homogenized using pellet pestles (Sigma-Aldrich, Denmark)
in a lysis buffer at pH 7.5 containing (in mM) 20 Tris-HCl, 150 NaCl, 5 ethylene glycol tetraacetic acid
(EGTA), 10 NaF, 20 b-glycerophosphate sodium salt, and HALT protease and phosphatase inhibitor
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cocktail (Thermo Scientific, Denmark). Samples were sonicated for 45 s and centrifuged at ~16,000 g
for 10 min. Total protein concentrations in the supernatants were measured using a bicinchoninic
acid (BCA) protein assay kit (Thermo Scientific); and 10 mg total protein diluted in Laemmlie sample
buffer (Biorad, Denmark) was loaded in each lane of an SDS polyacrylamide gel (Biorad). Membranes
were first probed with anti-eNOS (RRID:AB_304967; 0.2 mg/mL ab5589; Abcam, UK) or anti-pan-
actin (RRID:AB_2313904; 40 ng/mL #4968; Cell Signaling Technology, USA) primary antibody and
then with secondary goat anti-rabbit antibody (RRID:AB_2099233; 30 ng/mL #7074; Cell Signaling
Technology) conjugated to horseradish peroxidase. Bound antibody was detected by enhanced
chemiluminescence (ECL Plus; GE Healthcare, Denmark) using an ImageQuant LAS 4000 luminescent
image analyzer (GE Healthcare). Densitometric analyses were performed using ImageJ software
(RRID:SCR_003070; Rasband; NIH, USA). Band densities of eNOS relative to pan-actin were reported
after normalization to the average WT level.
Blood pressure measurements
Mice were anesthetized by subcutaneous injection of ketamine and xylazine (80 mg/kg Ketaminol
vet and 8 mg/kg Narcoxyl vet; Intervet International, The Netherlands) and placed on a thermostati-
cally controlled heating platform.
For telemetry-based measurements of resting blood pressure and effects of L-NAME ingestion,
the catheter of a telemetry transmitter (HD-X11; Data Sciences International, USA) was inserted in
the common carotid artery through a midline incision in the neck, and the transmitter body placed in
a subcutaneous pocket during stereomicroscopy. Pain relief was achieved through subcutaneous
injection of buprenorphine (0.2 mL/kg, Temgesic, Schering-Plough, Europe). Telemetry measure-
ments started one week after the operation. One 48 hr long registration at baseline was followed by
two 72 hr long registrations during which first 0.5 mg/mL and then 3 mg/mL L-NAME was added to
the drinking water. Telemetry signals were recorded for 10 s every minute using Dataquest A.R.T.
4.3 and analyzed with Ponemah 5.0 software (RRID:SCR_017107; Data Sciences International). We
evaluated daytime and nighttime blood pressure from 11 AM to 1 PM and 11 PM to 1 AM,
respectively.
For measurements of acute blood pressure responses to hyperventilation, a catheter was inserted
in the common carotid artery through a midline incision and connected to a pressure transducer
(MLT0699, ADInstruments). The mice were intubated and ventilated on a Minivent type 845 ventila-
tor (Harvard Apparatus, USA) at a frequency of 125 min 1 and with tidal volume adjusted until cap-
nography readings (Capnograph Type 240, Hugo-Sachs Electronics, Germany) showed an FETCO2 of
3.5%. During experiments, hypocapnia was induced by elevating the ventilation until FETCO2
decreased to 2%. Mean arterial blood pressure was derived from the pressure traces using the blood
pressure add-on for LabChart 8 Pro (ADInstruments). A few mice with an initial systolic blood pres-
sure below 70 mmHg were excluded from the analysis.
Laser speckle imaging
Mice were initially anesthetized by subcutaneous injection of ketamine (80 mg/kg) and xylazine (8
mg/kg) followed by injection with 1/4 the initial dose every 45 min. After endotracheal intubation,
mice were ventilated under capnography control as described above. The head of the anesthetized
mouse was fixed in an adaptor for a stereotaxic frame (World Precision Instruments, UK) while the
rest of the body was kept warm on a heating pad (Fine Science Tools Inc, Canada). The skin covering
the top of the skull was removed, the surface of the bone cleaned, and a coverslip mounted in aga-
rose in order to minimize optical reflections. Whiskers were fixed to a metal pole mounted on a cylin-
drical solenoid controlled by an Arduino circuit (Funduino Kit, Germany). The whiskers on one side
of the head were first stimulated by moving whiskers vertically with an amplitude of 8 mm and fre-
quency of 4 Hz. Then, the stimulation protocol was repeated on the opposite side of the head, and
the two responses were averaged for each mouse. Whisker stimulation was performed under control
conditions (FETCO2 = 3.5%) and after FETCO2 was reduced to 2% by mechanical hyperventilation.
Speckle images of 1088  1088 pixels were captured with a Basler acA2000-165uc camera
mounted on a VZM 200i Zoom Imaging Lens (Edmund Optics, USA) during transcranial illumination
with near-infrared laser light (CLD 1011LP, Thorlabs Inc, USA). Speckle data were analyzed with
MATLAB software (RRID:SCR_001622; MathWorks, USA). In each experiment, values were calculated
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for a region of interest (100  100 pixels) in the second posterior bifurcation of the middle cerebral
artery corresponding to the somatosensory barrel cortex contralateral to the whisker stimulation
(Aronoff and Petersen, 2008).
Arterial blood gas measurements
Arterial blood samples were collected through a catheter implanted in the common carotid artery of
anesthetized, intubated mice ventilated to normocapnia (FETCO2 = 3.5%) or experimental hypocap-
nia (FETCO2 = 2%) on a Minivent type 845 ventilator (Harvard Apparatus). The blood was immedi-
ately analyzed using an ABL80 Flex blood gas analyzer (Radiometer, Denmark).
Statistics of mouse experiments
Data are expressed as mean ± SEM and n equals number of mice (i.e. biological replicates). Proba-
bility (p) values less than 0.05 were considered statistically significant. Sample sizes were selected
based on previous experience (Boedtkjer et al., 2006; Boedtkjer et al., 2016c; Boedtkjer et al.,
2011; Thomsen et al., 2014) to allow detection of biologically relevant differences. If distributions
were approximately Gaussian and variances equal between groups, we compared (a) one variable
between two groups using unpaired two-tailed Student’s t-test, (b) one variable between three or
more groups using one-way ANOVA followed by Dunnett’s post-tests, and (c) effects of two varia-
bles on a third variable using two-way ANOVA followed by Sidak’s post-tests. If the distributions
showed unequal variance (i.e. p<0.05 by F test or by Brown-Forsythe and Bartlett’s tests) or signifi-
cant difference from normality (i.e. p<0.05 by D’Agostino and Pearson or Shapiro-Wilk normality
tests) due to right-skewness, we performed square root- or log-transformation. If variances were still
unequal, we compared one variable between two groups based on unpaired two-tailed t-tests with
Welch’s correction. If data distributions still did not pass normality tests, we used the non-parametric
Mann-Whitney test to compare one variable between two groups. Concentration-response relation-
ships were fitted to sigmoidal functions using least-square regression analyses, and the derived log
(EC50), Hill Slope, and bottom values were compared using extra sum-of-squares F-tests. Investiga-
tors were not blinded for genotype during experiments. Data processing and statistical analyses
were performed using Microsoft Office Excel 2016 (RRID:SCR_016137) and GraphPad Prism 7.05
(RRID:SCR_002798) software.
Burden analysis of loss-of-function variants
We studied association between rare variation in PTPRG and human ischemic vascular disease based
on exome sequencing data covering ~50,000 participants from the UK Biobank (RRID:SCR_012815),
which is a cohort with deep genetic and phenotypic data collected from the United Kingdom
(Bycroft et al., 2018; Van Hout et al., 2019).
Population-level variants (UK Biobank data field 23170) generated with the Functionally Equiva-
lent pipeline (Regier et al., 2018) were used after ensuring that the genomic region containing
PTPRG was unaffected by the current known error in the exome analysis protocol (UK Biobank
Resource 3802). We predicted the consequences of alternative alleles within the full-length transcript
for PTPRG (ENST00000474889.6) using the Ensembl Variant Effect Predictor (VEP) (McLaren et al.,
2016); and included in our analyses, the 334 missense variants localized outside exon-intron bound-
ary regions and 75 variants with predicted loss-of-function. Carriers of the identified variants were
extracted using the R-package qgg (Rohde et al., 2020). The identified loss-of-function variants
included 36 with low (intronic splice region variants, synonymous splice region variants), 17 with
moderate (in-frame insertions, in-frame deletions, missense splice region variants), and 22 with high
(splice acceptor variants, splice donor variants, stop-gain variants, frameshift variants) predicted
impact. In total, we identified 29,975 individuals who carried at least one missense variant and 195
individuals, who carried a variant with predicted loss-of-function. Of the 195 loss-of-function carriers,
123, 32, and 40 individuals carried variants with low, moderate, and high predicted impact,
respectively.
Known disease diagnoses for UK Biobank participants (data field 41270) were extracted from hos-
pital inpatient records coded according to the International Classification of Disease, version 10
(ICD-10; RRID:SCR_010349). Amongst the 49,953 participants with exome data, 2529 individuals
were diagnosed with angina pectoris (I20), 972 with acute myocardial infarction (I21), 392 with
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cerebral ischemia (I63), and 153 with vascular intestinal disorders (K55.0). Self-reported health status
was extracted for angina (data field 1074; reported by 1621 individuals), heart attack (data field
1075; reported by 1158 individuals), and stroke (data field 1081; reported by 686 individuals). We
further extracted MRI-based values for 12,851 exome-sequenced individuals for whom left ventricu-
lar ejection fraction (data field 22420) was available from a fully automated analysis approach that
has shown good correlation with manual analysis results performed by trained readers
(Suinesiaputra et al., 2018). The cardiac MRI data set included 6482 carriers of missense PTPRG var-
iants, 32 carriers of low impact loss-of function variants, 13 carriers of moderate impact loss-of-func-
tion variants, and 13 carriers of high impact loss-of-function variants.
We performed logistic regression analyses to calculate odds ratios (± SEM) for carrying missense
or predicted loss-of-function PTPRG variants when diagnosed with ischemic vascular disease. We fist
evaluated acute ischemic vascular disease as a whole for the brain, heart, and intestine (aggregate
of ICD-10 diagnosis codes I20, I21, I63, and K55.0). For the group of individuals carrying a predicted
loss-of-function variant of moderate or high impact, we then calculated separate odds ratios for I20,
I21, and I63. The number of exome-sequenced participants in the UK Biobank diagnosed with K55.0
was too low for a meaningful separate statistical analysis. We next evaluated association of the
PTPRG loss-of-function variants with self-reported angina, heart attack, and stroke. Finally, we evalu-
ated the relation between carrier status for PTPRG variants and left ventricular ejection fraction by
multiple linear regression analysis. The logistic as well as multiple linear regression analyses were
corrected for sex (data field 31), age (data field 21022), body mass index (data field 21001), the first
four genetic principal components (data field 22009), smoking status (data field 20116), dyslipidemia
(ICD-10 diagnosis code E78.5), diabetes mellitus (ICD-10 diagnosis code E11), and hypertension
(ICD-10 diagnosis code I10).
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Voss NCS, Dreyer T, Henningsen MB, Vahl P, Honoré B, Boedtkjer E. 2020. Targeting the acidic tumor
microenvironment: unexpected pro-neoplastic effects of oral NaHCO3 therapy in murine breast tissue. Cancers
12:891. DOI: https://doi.org/10.3390/cancers12040891
Wahl M, Deetjen P, Thurau K, Ingvar DH, Lassen NA. 1970. Micropuncture evaluation of the importance of
perivascular pH for the arteriolar diameter on the brain surface. Pflügers Archiv European Journal of Physiology
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